Orion Biotechnology Canada raised US $5M in late 2017 from undisclosed Canadian and international investors.
Cipher Pharmaceuticals to acquire Canadian business portfolio of Cardiome Pharma for $25.5M. Cardiome non-Canadian assets and liabilities will be held by newly formed Correvio Pharma
FV Pharma completed new round of financing with Canadian and international investors
Farmacopeia, a female focused medical cannabis company, closed new financing
PureSinse entered into going-public agreement with Royal Sapphire (TSX-V: RSL) which will result a reverse take-over of Royal Sapphire.
The Green Organic Dutchman Holdings to raise up to $115 million in initial public offering on TSX at a valuation of just over $1 billion.
PureSinse, a Licensed Producer under ACMPR, completed new round of financing
Patricia Industries owned Laborie to acquire Cogentix Medical (NASDAQ: CGNT) from Accelmed Growth Partners and Lewis Pell for US $239M
Quinsam Capital invested in Aleafia, ALQ Gold, C21 Investments, Cannex, Cannabiverse, Cannabis OneFive, City View Green, Cultivator Catalyst, Evergreen, HarvestOne, Hemp Hydrate, High Hampton, Hydropothecary, Phytopharma, Sproutly, Westleaf Cannabis
Feldan Therapeutic raised additional Series B round of funding
Fire Cannabis, dba SLANG WORLDWIDE, closed $16.7M Special Warrant offering co-led by Canaccord Genuity Corp. and Clarus Securities Inc.
Ontario government announced new initiative to invest up to $50 million in venture capital funds focused on life sciences.